Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years.
oleh: Piero L Olliaro, Annette C Kuesel, Christine M Halleux, Mark Sullivan, John C Reeder
| Format: | Article |
|---|---|
| Diterbitkan: | Public Library of Science (PLoS) 2018-11-01 |
Deskripsi
No description available for this item.